The use of the Female Intervention Efficacy Index (FIEI) as an immediate outcome measure of medical intervention to treat female sexual dysfunction.
Many medications used in the treatment of male erectile dysfunction are still in the experimental phases for use in women. Numerous pharmacological options for women presently under testing include the EROS-CTD clitoral therapy device (Berman et al., 1999b; Billups et al., 2001). In addition to the new medical developments for treating female sexual dysfunction, methods for evaluating sexual responses and efficacy of intervention are evolving as well.
Berman
L A
LA
Division of Urology, UCLA Medical Center, 924 Westwood Ave., #520, Los Angeles, CA 90024, USA.
Berman
J R
JR
Werbin
T
T
Chabra
S
S
Goldstein
I
I
D000293:Adolescent; D000328:Adult; D002987:Clitoris / Q000098:blood supply*; D005260:Female; D006801:Humans; D010549:Personal Satisfaction; D010812:Physical Stimulation / Q000295:instrumentation; D010865:Pilot Projects; D017698:Postmenopause / Q000502:physiology; D017697:Premenopause / Q000502:physiology; D012677:Sensation / Q000502:physiology; D012720:Severity of Illness Index; D020018:Sexual Dysfunctions, Psychological / Q000175:diagnosis* / Q000628:therapy*; D011795:Surveys and Questionnaires; D016896:Treatment Outcome